Dipna Pharmachem Ltd - 543594 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74(5) of SEBI (Depository and Participant) Regulation, 2018 for the quarter and Nine Months ended on 31st December, 2022 Dipna Pharmachem Ltd - 543594 - Notice Of Extra Ordinary General Meeting.
We hereby inform you that the Board of Directors of the Company has decided to call Extra Ordinary General Meeting of the Company to be held on Saturday, 4th February, 2023 at 4:00 P.M through VC/OAVM. Notice of Extra Ordinary General Meeting of the Company is enclosed. The Company is providing remote E-voting facility to all the shareholders of the Company. The Company has set 28th January, 2023 as the 'Cut-off Date' for taking record of the shareholders of the Company who will be eligible for casting their vote on the resolution to be passed in Extra Ordinary General Meeting for remote E-voting. The remote e-voting period begins on 1st February, 2023 at 9:00 A.M. and ends on 3rd February, 2023 at 5:00 P.M. Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 11Th January, 2023.
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today i.e. 11th January, 2023 at the Registered Office of the Company which commenced at 5:30 P.M. and concluded at 6:00 P.M., has decided to hold Extra Ordinary General Meeting of the Company on Saturday, 4th February, 2023 at 4:00 P.M. Dipna Pharmachem Ltd - 543594 - Submission Of Unaudited Financial Results For The Half Year Ended On 30Th September, 2022 Along With Limited Review Report
In reference to captioned subject and pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby submitting the Unaudited Financial Results for the Half Year ended on 30th September, 2022 along with Limited Review Report. Please take note of the same and oblige. Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 14Th November, 2022
Pursuant to second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e. on 14th November, 2022, at the Registered Office of the Company, which commenced at 5:30 P.M. and concluded at 6:00 P.M., has considered and approved the Unaudited Financial Results along with Limited Review Report for the Half Year ended on 30th September, 2022. Please take note of the same and oblige. Dipna Pharmachem Ltd - 543594 - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th November, 2022
Dipna Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on 14th November, 2022 at 5:30 P.M. at the registered office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055 inter alia, to consider and approve the Unaudited Financial Results of the Company for the Half Year ended on 30th September, 2022 along with Limited Review Report. Please take note of the same and oblige. Dipna Pharmachem Ltd - 543594 - Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 8Th November, 2022
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their Meeting held on today i.e. 8th November, 2022 which commenced at 5:30 PM and concluded at 7:00 PM, has appointed M/s. Devadiya & Associates., Chartered Accountants, (FRN: 123045W) as the Statutory Auditor of the Company subject to the approval of the shareholder in general meeting for Financial Year 2022-23 to fill the casual vacancy. Kindly take same on your record and oblige us. Dipna Pharmachem Ltd - 543594 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
With reference to the captioned subject, we hereby submit the confirmation Certificate received from M/s. Bigshare Services Private Limited. Registrar and Share Transfer Agent (RTA) as per Regulation 74(5) of the Securities and Exchange Board India (Depository and Participant) Regulations, 2018 for the Quarter and half year ended on 30th September, 2022. Kindly take the same on your record and oblige us. Thanking You Dipna Pharmachem Ltd - 543594 - Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Keyur ShahDesignation :- Managing Director / Whole Time Director Dipna Pharmachem Ltd - 543594 - Closure of Trading Window
Pursuant to Clause 4 of Schedule B of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time and Company's Code of Internal Procedures and Conduct for Prevention of Insider Trading in Securities, this is to inform that the trading window for dealing in Equity Shares of the Company by the Insiders will be closed from Saturday, 1st October, 2022 till 48 hours after the declaration and publication of Unaudited Financial Results for thefor the Quarter and half year ended on 30th September, 2022. Please take note of the same and oblige.